Cat FIP: The Welfare Revolution from Fatal to Treatable Disease

Feline infectious peritonitis (FIP), once nearly always fatal, is now treatable with antiviral drugs. This dramatic development has transformed the welfare outcomes for cats diagnosed with this previously devastating disease.

Key Facts

FIP is caused by a mutated form of feline enteric coronavirus (FECV) that becomes systemic and virulent
Before antiviral treatments, FIP had a near 100% fatality rate - affected cats were typically euthanized within weeks of diagnosis
GS-441524 (an adenosine nucleoside analog) and GC376 (a protease inhibitor) demonstrated dramatic efficacy in treating FIP in 2018-2019 research
Remission rates with GS-441524 of 80-90% were documented in clinical trials, representing a revolutionary therapeutic advance
Treatment requires a minimum 12-week course of daily medication, with follow-up monitoring for relapse
Neurological and ocular FIP forms are more challenging to treat and require higher drug doses to achieve CNS penetration
Molnupiravir and Mefloquine have also shown efficacy and are under investigation as treatment options
FIP treatment drugs have become commercially available in many countries following regulatory approval processes

Welfare Considerations

The transformation of FIP from a death sentence to a treatable disease is one of the most significant welfare advances in feline medicine in decades. Cats diagnosed with FIP previously faced a trajectory of rapid deterioration - fluid accumulation, cachexia, neurological signs - followed by euthanasia within weeks. The emotional impact on owners and the physical suffering of cats during this period was significant. Effective antiviral treatment changes this profoundly - cats that would have died are completing treatment and living normal lives. The welfare implications extend beyond individual cats to the mental wellbeing of their owners and the profession's capacity to offer hope. Challenges remain: treatment costs are significant, access to approved products varies by country, and the risk of relapse requires monitoring. But the welfare trajectory has shifted fundamentally from certain death to high probability of recovery.

What You Can Do

If your cat is diagnosed with FIP, immediately consult with a veterinarian familiar with antiviral treatment options
Seek a second opinion from a feline specialist or internal medicine specialist if FIP is suspected but treatment has not been discussed
Research current treatment availability in your country - approved products and access through informed vets varies regionally
Understand the treatment protocol: minimum 12 weeks of daily medication, followed by monitoring for relapse
Connect with FIP owner communities for support, shared experience, and guidance on accessing treatment
Be aware of cost - FIP treatment is expensive; discuss financial planning and consider whether insurance will cover it
Monitor for relapse signs (return of fever, lethargy, fluid) after completing treatment
Advocate for broader access to FIP antivirals and awareness among vets to ensure all FIP-affected cats receive treatment